DOSSIET

FDA Panel Recommends Pulling Preterm Birth Drug From the Market

Written by

Christina Jewett

in

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

Christina Jewett
Author: Christina Jewett

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts